Intelomed
Early Stage
Real-time Remote Health Metrics
Overview
Raised: $98,095
Total Commitments ($USD)
Platform
StartEngine
Start Date
10/11/2022
Close Date
01/10/2023
Min. Goal
$10,000
Max. Goal
$1,069,999
Min. Investment
$101
Security Type
Equity - Preferred
Series
Seed
Funding Type
RegCF
Price Per Share
$1.20
Pre-Money Valuation
$28,087,014
Rolling Commitments ($USD)
Status
Funded
Reporting Date
01/31/2023
Days Remaining
Funded
% of Min. Goal
981%
% of Max. Goal
9%
Likelihood of Max
Funded
Avg. Daily Raise
$1,078
# of Investors
35
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location
Cranberry Township, Pennsylvania
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B/B2C
Margin
Medium
Capital Intensity
Low
Intelomed, with a valuation of $28.1 million, is raising funds on StartEngine. The company is developing a contactless patient-monitoring device to improve telehealth treatment outcomes. The technology of Intelomed uses the camera of a smartphone combined with its Mobile Cardiovascular Insight to measure the microchanges in a patient’s facial color to provide valuable diagnostics to clinicians. Intelomed is led by an experienced team and aims to improve treatment capabilities drastically. William P. Malloy founded Intelomed in February 2005. The current crowdfunding campaign has a minimum target of $9,999.60 and a maximum target of $1.07 million. The campaign proceeds will be used to pursue FDA clearance.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$33,203 |
$14,150 |
|
COGS |
$3,752 |
$70 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-1,266,445 |
$-1,265,112 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$267,374 |
$738,197 |
|
Accounts Receivable |
$14,760 |
$3,440 |
|
Total Assets |
$513,556 |
$991,820 |
|
Short-Term Debt |
$108,150 |
$102,511 |
|
Long-Term Debt |
$5,334,624 |
$4,552,082 |
|
Total Liabilities |
$5,442,774 |
$4,654,593 |
Financials as of: 10/11/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
